Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Investigating Use of Submucosal Injection of EverLift in Rates of Complete Resection of Nonpedunculated Polyps 4-9mm

NCT04551014 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04551014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Investigating Use of Submucosal Injection of EverLift in Rates of Complete Resection of Nonpedunculated Polyps 4-9mm
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2020
Completion date
July 15, 2021
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenomatous polyp of colon, colo-rectal cancer, polyp of colon